The proportion of GPs (%) who agreed that each of the 14 factors influenced their willingness to prescribe (n = 672)
| Factor | Willing, n (%) (N= 540) | Unwilling,n (%) (N= 132) |
|---|---|---|
| Benefits of aspirin | 527 (97.6) | 113 (85.6) |
| Harms of aspirin | 472 (87.4) | 121 (91.7) |
| Dose of aspirin asked to prescribe | 455 (84.3) | 112 (84.8) |
| Prescribing aspirin off-label | 369 (68.3) | 110 (83.3) |
| Geneticist recommendation to prescribe | 492 (91.1) | 93 (70.5) |
| Patients’ interest in using aspirin | 491 (90.9) | 86 (65.2) |
| Patients’ awareness of the harms and benefits of aspirin | 519 (96.1) | 104 (78.8) |
| Wanting to speak to specialist in genetics before prescribing | 235 (43.5) | 86 (65.2) |
| Wanting to speak to specialist in colorectal cancer before prescribing | 224 (41.5) | 96 (72.7) |
| Wanting to speak with another GP before prescribing | 227 (42.0) | 74 (56.1) |
| Patients’ age | 375 (69.4) | 78 (59.1) |
| Confidence in aspirin in general | 478 (88.5) | 92 (69.7) |
| Confidence in aspirin as a form of preventive therapy | 451 (83.5) | 104 (78.8) |
| Prescribing budget in your practice | 132 (24.4) | 28 (21.2) |